For many patients who could genuinely benefit from TMS or Spravato, the financial dimension of treatment is the primary obstacle between considering it and actually starting. This is partly a knowledge problem. The landscape of costs, coverage, and prior authorisation processes is genuinely complex, and patients who do not know where to look for answers […]
Continue Reading